JP Morgan Chase
ICVX

JP Morgan Chase’s Icosavax, Inc. Common Stock ICVX Stock Holding History

JP Morgan Chase’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,594
Closed -$466K – 8065
2023
Q4 		$466K Buy
29,594
+10,765
+57% +$104K ﹤0.01% 4845
2023
Q3 		$146K Sell
18,829
-2,664
-12% -$22.1K ﹤0.01% 5263
2023
Q2 		$213K Buy
21,493
+4,328
+25% +$34.6K ﹤0.01% 5039
2023
Q1 		$100K Buy
17,165
+1,986
+13% +$17.2K ﹤0.01% 5431
2022
Q4 		$121K Sell
15,179
-540
-3% -$2.32K ﹤0.01% 5278
2022
Q3 		$50K Sell
15,719
-46,764
-75% -$293K ﹤0.01% 5553
2022
Q2 		$358K Buy
62,483
+42,935
+220% +$335K ﹤0.01% 4754
2022
Q1 		$138K Buy
19,548
+7,883
+68% +$124K ﹤0.01% 5368
2021
Q4 		$268K Buy
11,665
+6,737
+137% +$174K ﹤0.01% 5187
2021
Q3 		$146K Buy
+4,928
New +$167K ﹤0.01% 5386

JP Morgan Chase's ICVX Position: Q1 2024 in Review

JP Morgan Chase sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 29,594 shares — an estimated $466K sold.

JP Morgan Chase first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $466K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • JP Morgan Chase reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 29,594 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $466K.
  • JP Morgan Chase first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • JP Morgan Chase's Icosavax, Inc. Common Stock position peaked at $466K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.